Pretreatment and follow-up variables of patients with type 1 diabetic mellitus undergoing autologous nonmyeloablative hematopoietic stem cell transplantation.

aDuration referred to duration time from appearance of symptoms of hyperglycemia to treatment of AHST (mo);
bFBG (mmol/L);
cPBG(mmol/L);
dHbA1c (%);
eGADA (U/mL);
fP value, comparison between IF group (patient 1, 2, 3, 4, 6, 9) and ID group (patient 5, 7, 8) using Mann-Whitney test;
gC-peptide (ng/mL); - represent the data did not been acquired.